Cardiac-Specific YAP Activation Improves Cardiac Function and Survival in an Experimental Murine MI Model

Cardiac-specific YAP activation after MI mitigated myocardial injury, improved cardiac function, and enhanced survival. These findings suggest that therapeutic activation of YAP or its downstream targets, potentially through AAV-mediated gene therapy, may be a strategy to improve outcome after MI.